- Led a multidisciplinary project to develop novel CAR-T cell technology- Spearheaded a CAR-T cell engineering and research pipeline- Pioneered adoptive cell transfer and synthetic biology strategies to develop a first-in-class cell therapy platform that delivers small molecules directly to the tumor microenvironment

- Identified an unmet need in the at-home diagnostic market for patients suffering from neutropenia- Awarded 2nd place at the Columbia University Engineering Venture Competition with seed funding award- Awarded best team at the NYC Regional Innovation Node (NYCRIN) I-Corps program

- Developed platforms for screening and identification of antiviral small molecules and monoclonal antibodies- Discovered broadly neutralizing antibodies targeting human cytomegalovirus which have been advanced for preclinical development- Identified and characterized a highly conserved neutralizing epitope of an essential cytomegalovirus glycoprotein

- Investigated molecular and biochemical mechanisms of humoral immune response in Type I Diabetes- Conducted radio-immunoprecipitation assays in serum of pre-diabetic patients- Identified a novel auto-antigen involved in Type I Diabetes, ATP4A

Worked as a bilingual educator at a primary school in Madrid. Developed curricula for bilingual science and reading programs.

Chemical formulation technician for the development of EN3285 for treatment or Oral Mucositis.

Worked in the lab of Dr. Michael Klymkowsky. Investigated developmental and molecular mechanisms in Xenopus laevis. Successfully completed a senior honor’s thesis and defense in Fall 2006, entitled: Studies of SOX7 as a Component of Germ Plasm in Xenopus laevis